BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: He WM, Li WS. Investigating radiotherapy’s impact on intestinal perforation risk in gastrointestinal tumor patients treated with bevacizumab. World J Gastrointest Oncol 2025; 17(12): 110621 [PMID: 41480214 DOI: 10.4251/wjgo.v17.i12.110621]
URL: https://www.wjgnet.com/1948-5204/full/v17/i12/110621.htm
Number Citing Articles
1
Yan Xu, Xiao-Bing Huang, Yong-Gang He. Radiotherapy combined with bevacizumab in gastrointestinal cancers: Balancing efficacy against the risk of intestinal perforationWorld Journal of Radiology 2026; 18(1): 116084 doi: 10.4329/wjr.v18.i1.116084